๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for HBV

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Methylene Blue Treatment of Chronic Hepatitis B Virus Infection NCT06887036Phase 21 site๐Ÿ“ Lugano Fondazione Epatocentro Ticino ยท Tests: Methylene Blue Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease NCT06372990n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus NCT06364930Phase 41 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Dapagliflozin 10mg Tab, Placebo 10mg Tab Pegylated Interferon ฮฑ in Previously Interferon-treated CHB๏ผˆLeading Study๏ผ‰ NCT06323681NA1 site๐Ÿ“ Shanghai Qing XIe ยท Tests: Peginterferon ฮฑ-2b based treatment group, NAs monotherapy group Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) NCT03792919Phase 41 site๐Ÿ“ Hong Kong Humanity & Health Medical Group Limited ยท Tests: Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV neucleos(t)ides) Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: Nucleos(t)ide Analogs (NA) Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF NCT03920618NA1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University ยท Tests: Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B NCT07606950Phase 31 site๐Ÿ“ Guangzhou Fujian Shengdi Pharmaceutical Co., Ltd. ยท Tests: HRS-5635 Injection, Placebo TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load. NCT05195450NA1 site๐Ÿ“ New Delhi Institute of Liver and Biliary Sciences, India ยท Tests: Tenofovir alafenamide fumarate Evaluation of Patients With Liver Disease NCT00001971n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729) NCT06277037n/a18 sites๐Ÿ“ San Diego๐Ÿ“ Miami๐Ÿ“ Hillsborough Arbutus Biopharma Corporation ยท Tests: Non-interventional ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB) NCT07741461Phase 11 site๐Ÿ“ Shanghai Xiamen Amoytop Biotech Co., Ltd. ยท Tests: ACT201 Injection, ACT201 Injection Placebo Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B NCT04896255n/a1 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: peginterferon alpha based regimen, nucleos(t)ide Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance NCT07257562n/a1 site๐Ÿ“ Fuzhou First Affiliated Hospital of Fujian Medical University ยท Tests: PegIFNฮฑ2b+Nucleoside analog, PegIFNฮฑ2b+Nucleoside analog+Bacteroides fragilis+Branched-Chain Amino Acids Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide NCT07429864n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B NCT03933384Phase 41 site๐Ÿ“ Taichung Taichung Veterans General Hospital ยท Tests: Tenofovir alafenamide, Entecavir TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site๐Ÿ“ Baltimore University of Maryland, Baltimore ยท Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants NCT06544863n/a3 sites๐Ÿ“ Paris๐Ÿ“ Paris๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Data collection; biological samples Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection NCT07610772Phase 12 sites๐Ÿ“ Aarhus๐Ÿ“ Berlin Aarhus University Hospital ยท Tests: HepB mAb19 Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria NCT06834178n/a1 site๐Ÿ“ Graz Vanessa Stadlbauer-Koellner, MD Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis NCT07413549Phase 1, Phase 21 site๐Ÿ“ Wuhan Beijing Tuohua Weiye Biotechnology Co., Ltd. ยท Tests: Human Umbilical Cord Mesenchymal Stem Cells Injection A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B NCT07389044Phase 15 sites๐Ÿ“ Hong Kong๐Ÿ“ Hong Kong๐Ÿ“ Chisinau IntegerBio ยท Tests: IB-001, Placebo, Peginterferon Alfa-2A Adaptability of an Undetectable = Untransmissible Model for HBV NCT07449091n/a1 site๐Ÿ“ New York NYU Langone Health Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B NCT06671093Phase 13 sites๐Ÿ“ Hong Kong๐Ÿ“ Chisinau๐Ÿ“ Auckland Tune Therapeutics, Inc. ยท Tests: Tune-401 Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA. NCT04231565NA1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University ยท Tests: Tenofovir alafenamide Fumarate Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis NCT05905172Phase 323 sites๐Ÿ“ Beijing๐Ÿ“ Shanghai๐Ÿ“ Beijing Beijing Continent Pharmaceutical Co, Ltd. ยท Tests: Hydronidone capsules, The placebo capsules ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection NCT07573943Phase 41 site๐Ÿ“ Chongqing The Second Affiliated Hospital of Chongqing Medical Universโ€ฆ ยท Tests: Anti-PD-L1 antibody (ASC22), Nucleotide analogs, Peg-IFNฮฑ Research on Clinical Recovery and Maintenance Strategies for CHB NCT06803368NA1 site๐Ÿ“ Beijing Beijing Municipal Administration of Hospitals ยท Tests: baseline anti-HBs titer A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma NCT07557251Phase 11 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: BRII-5395, Sintilimab, Bevacizumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy